KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160,800 | -83.4% | 120,000 | -77.8% | 0.01% | -82.9% |
| Q2 2023 | $966,138 | -45.2% | 539,742 | +96.8% | 0.04% | -63.9% |
| Q4 2021 | $1,763,000 | +424.7% | 274,243 | +375.1% | 0.10% | +470.6% |
| Q3 2021 | $336,000 | -96.8% | 57,726 | -94.3% | 0.02% | -95.8% |
| Q2 2021 | $10,371,000 | -25.9% | 1,004,962 | -24.5% | 0.40% | -10.7% |
| Q1 2021 | $14,003,000 | +245.6% | 1,331,104 | +408.6% | 0.45% | +118.4% |
| Q4 2020 | $4,052,000 | +16.5% | 261,729 | +9.9% | 0.21% | -12.7% |
| Q3 2020 | $3,477,000 | +81.3% | 238,104 | +135.2% | 0.24% | +98.3% |
| Q2 2020 | $1,918,000 | +253.2% | 101,249 | +257.9% | 0.12% | +83.1% |
| Q1 2020 | $543,000 | -15.6% | 28,290 | -15.6% | 0.06% | +41.3% |
| Q4 2019 | $643,000 | -78.4% | 33,535 | -89.2% | 0.05% | -79.4% |
| Q3 2019 | $2,978,000 | – | 309,579 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |